Effect of Steroid Treatment on Tissue Damage Markers in Diabetic Patients
Mohammed Shakir Ali 1*, Ali Al-Shammari 1, Qutaiba A. Ismael 1, Obaida Amer Imran 1, Mohammed H. Al-Bayati 1
Journal of Angiotherapy 8(1) 1-10 https://doi.org/10.25163/angiotherapy.819442
Submitted: 20 December 2023 Revised: 21 January 2024 Published: 22 January 2024
Abstract
Steroid-induced hyperglycemia challenges primary care providers. Understanding and managing these effects are insufficient despite widespread glucocorticoid use. Our study aimed to investigate the impact of steroid treatment on tissue damage markers in diabetic patients. We determined the liver enzymes, blood biochemistry, and interleukins (IL-12, IL-17A, IL-6, and IL1B) before and after steroid treatment. The results revealed a significant increase in creatinine levels among the active patients compared to the control group. The mean concentrations of ALT and ALP in the active patients (on steroids) were 43 ± 3.1 and 112 ± 10.2 U/L, respectively, significantly higher than the active control (24 ± 5.1). Our study also found that IL-12, IL-17A, IL-6, and IL-10 were upregulated 5.2, 16.2, 2.13, and 5.11 times, respectively, compared to the control. The blood sugar levels (RBS) showed positive correlations with Neutrophils (r = 0.81, P = 0.012), IL-12 (r = 0.68, P = 0.028), and IL-6 (r = 0.51, P = 0.03). In conclusion, our research demonstrated the significance of inflammation and tissue damage in the expression patterns associated with type 2 diabetes and its effects.
Keywords: Steroid-induced hyperglycemia, Glucocorticoid, Tissue damage markers, Interleukins (IL-12, IL-17A, IL-6, IL-1B), Type 2 diabetes
References
A.M. Arruda-Olson, G.S. Reeder, M.R. Bell, S.A. Weston, V.L. Roger. Neutrophilia predicts death and heart failure after myocardial infarction: a community-based study. Circ. Cardiovasc. Qual. Outcomes, 2 (4) (2009), pp. 656-662
Afarideh M, Aryan Z, Ghajar A, Ganji M, Ghaemi F, Saadat M, et al. Association of non-alcoholic fatty liver disease with microvascular complications of type 2 diabetes. Primary Care Diabetes (2019) 13(6):505–14. doi: 10.1016/j.pcd.2019.03.009
Akter S, Rahman MM, Abe SK, Sultana P. Prevalence of diabetes and prediabetes and their risk factors among Bangladeshi adults: a nationwide survey. Bull World Health Organ. 2014;92:204–13.
Aminlari M, Vaseghi T. A new colorimetric method for determination of creatine phosphokinase. Anal Biochem 1987; 164: 397--404
Anderson JL, Ronnow BS, horne BD, Carlquist JF, May HT, et al. Usefulness of a complete blood count-derived risk score to predict incident mortality in patients with suspected cardiovascular disease. Am J Cardiol. 2007; 99: 169-174. Ref.: https://goo.gl/DKomPT
Ballestri S, Zona S, Targher G, Romagnoli D, Baldelli E, Nascimbeni F, et al. Nonalcoholic fatty liver disease is associated with an almost twofold increased risk of incident type 2 diabetes and metabolic syndrome. Evidence from a systematic review and meta-analysis. Journal of gastroenterology and hepatology. 2016;31(5):936–44.
Butterworth J. Changes in nine enzyme markers for neurons, glia, and endothelial cells in agonal state and Huntington’s disease caudate nucleus. Journal of Neurochemistry. 1986;47(2):583–587. doi: 10.1111/j.1471-4159.1986.tb04539.x.
Cavusoglu e, Chopra V, Gupta A, Battala V R, Poludasu S, et al. Relation between red blood cell distribution width (RDW) and all-cause mortality at two years in an unselected population referred for coronary angiography. Int J Cardiol. 2009; 28: 141-146. Ref.: https://goo.gl/vXBgJM
Chitturi S, Farrell GC. Corticosteroids. Adverse effects of hormones and hormone antagonists on the liver. In, Kaplowitz N, DeLeve LD, eds. Drug-induced liver disease. 3rd ed. Amsterdam: Elsevier, 2013, pp. 613-4.
Cortvrindt, C., Speeckaert, R., Moerman, A., Delanghe, J.R. and Speeckaert, M.M. (2017) The Role of Interleukin-17A in the Pathogenesis of Kidney Diseases. Pathology, 49, 247-258.
https://doi.org/10.1016/j.pathol.2017.01.003
Czock D, Keller F, Rasche FM, Haussler U. Pharmacokinetics and pharmacodynamics of systemically administered glucocorticoids. Clin Pharmacokinet. 2005;44:61–98.
Dacie and Lewis, Practical Haematology, Eleventh Edition, 2011
Eizadi M, Kohandel M, Kasbparast J et al. (2011): Serum interleukin-1 beta plays an important role in insulin secretion in type II diabetic. International Journal of Biosciences, 3: 93-99.
Fève B, Bastard JP. The role of interleukins in insulin resistance and type 2 diabetes mellitus. Nat Rev Endocrinol. 2009 Jun;5(6):305-11. doi: 10.1038/nrendo.2009.62. PMID: 19399017.
Gan T, Cheng N, Ding J, Cheng Z, Zhang D, Li H, et al. Effects of hepatitis b virus infection, alanine aminotransferase, aspartate aminotransferase and gamma-glutamyl transferase on prediabetes and diabetes mellitus: A cohort study. Ann Hepatol (2020) 19(2):197–203. doi: 10.1016/j.aohep.2019.08.008
Giacco F, Brownlee M. Oxidative stress and diabetic complications. Circ Res. 2010 Oct 29;107(9):1058-70. doi: 10.1161/CIRCRESAHA.110.223545. PMID: 21030723; PMCID: PMC2996922.
Haghighi S, Amini M, Pournaghshband Z, Amini P, Hovsepian S. Relationship between gamma-glutamyl transferase and glucose intolerance in first degree relatives of type 2 diabetics patients. J Res Med Sci. 2011 Feb;16(2):123-9. PMID: 22091220; PMCID: PMC3214292.
Hua S, Qi Q, Kizer JR, Williams-Nguyen J, Strickler HD, Thyagarajan B, et al. Association of liver enzymes with incident diabetes in us hispanic/latino adults. Diabetic Med J Br Diabetic Assoc (2021) 38(8):e14522. doi: 10.1111/dme.14522
Hwang JL, Weiss RE. Steroid-induced diabetes: a clinical and molecular approach to understanding and treatment. Diabetes Metab Res Rev. 2014 Feb;30(2):96-102. doi: 10.1002/dmrr.2486. PMID: 24123849; PMCID: PMC4112077.
Kanta P, Ghosh T, Kaur A, Muthukumarappa T. An innovative and cost-effective way to estimate alkaline phosphatase activity in in vitro cellular model systems. Int J Biochem Mol Biol. 2021 Feb 15;12(1):1-7. PMID: 33824775; PMCID: PMC8012822.
Kirschke E, Goswami D, Southworth D, Griffin PR, Agard DA. Glucocorticoid receptor function regulated by coordinated action of the Hsp90 and Hsp70 chaperone cycles. Cell. 2014;157:1685–1697.
Maedler K, Dharmadhikari G, Schumann D et al. (2007): Interleukin-1 beta targeted therapy for type 2 diabetes. Expert Opin Biol Ther., 9 (9), 1177-88.
Mandal A, Bhattarai B, Kafle P, Khalid M, Jonnadula SK, Lamicchane J, Kanth R, Gayam V. Elevated Liver Enzymes in Patients with Type 2 Diabetes Mellitus and Non-alcoholic Fatty Liver Disease. Cureus. 2018 Nov 23;10(11):e3626. doi: 10.7759/cureus.3626. PMID: 30697502; PMCID: PMC6347442.
Mehak Narjis, Mamoona Noreen, Sher Zaman Safi, Naureen Ehsan Ilahi, Suliman Yousef Alomar, Afrah Fahad Alkhuriji, Cross talk between complete blood count and progression of type II diabetes mellitus, Journal of King Saud University - Science, Volume 33, Issue 6, 2021, 101492, https://doi.org/10.1016/j.jksus.2021.101492.
Mirza M, Christine M, Perla M et al. (2011): Type 2- Diabetes is associated with elevated levels of TNF-alpha, IL-6 and adiponectin and low levels of leptin in a population of Mexican American: A Cross-Sectional Study.J Ccyto., 11: 132-138.
Mishra M., Kumar H., Bajpai S., Singh R.K., Tripathi K. Level of serum IL-12 and its correlation with endothelial dysfunction, insulin resistance, proinflammatory cytokines and lipid profile in newly diagnosed type 2 diabetes. Diabetes Res Clin Pract. 2011;94:255–261.
Morris D (2018) Steroid-induced diabetes and hyperglycaemia. Part 1: mechanisms and risks. Diabetes & Primary Care 20: 151–3
Mozo G., del Olmo M. L., Caro-Patón A., et al. Pulmonary injuries and cytokine levels after the intraperitoneal administration of pancreatic homogenates in rats. Revista Española de Enfermedades Digestivas. 2004;96(8):527–533. doi: 10.4321/s1130-01082004000800002.
Oluwatobi T. Somade, Babatunji E. Oyinloye, Bashiru O. Ajiboye, Olukemi A. Osukoya, Olubisi E. Adeyi, Effect of syringic acid on steroid and gonadotropic hormones, hematological indices, sperm characteristics and morphologies, and markers of tissue damage in methyl cellosolve-administered rats, Biochemistry and Biophysics Reports, Volume 32, 2022, 101360, https://doi.org/10.1016/j.bbrep.2022.101360.
Ravid M, Brosh D, Ravid-Safran D, Levy Z, Rachmani R. Main risk factors for nephropathy in type 2 diabetes mellitus are plasma cholesterol levels, mean blood pressure, and hyperglycemia. Arch Intern Med. 1998; 158: 998-1004. Ref.: https://goo.gl/k26UT8
Rehman K, Akash MSH, Liaqat A, Kamal S, Qadir MI, Rasul A. Role of Interleukin-6 in Development of Insulin Resistance and Type 2 Diabetes Mellitus. Crit Rev Eukaryot Gene Expr. 2017;27(3):229-236. doi: 10.1615/CritRevEukaryotGeneExpr.2017019712. PMID: 29199608.
Roberts A, James J, Dhatariya K; Joint British Diabetes Societies (JBDS) for Inpatient Care (2018) Management of hyperglycaemia and steroid (glucocorticoid) therapy: a guideline from the Joint British Diabetes Societies (JBDS) for Inpatient Care group. Diabet Med 35: 1101–17
Rudiger, A., Burckhardt, O.A., Harpes, P., Muller, S.A., and Follath, F. (2006); (2009). The relative lymphocyte count on hospital admission is a risk factor for long-term mortality in patients with acute heart failure. Am. J. Emerg. Med., 5(3) :451–4.
Schijvens AM, Ter Heine R, de Wildt SN, Schreuder MF. Pharmacology and pharmacogenetics of prednisone and prednisolone in patients with nephrotic syndrome. Pediatr Nephrol. 2019 Mar;34(3):389-403. doi: 10.1007/s00467-018-3929-z. Epub 2018 Mar 16. PMID: 29549463; PMCID: PMC6349812.
Shields C. J., Winter D. C., Manning B. J., Wang J. H., Kirwan W. O., Redmond H. P. Hypertonic saline infusion for pulmonary injury due to ischemia-reperfusion. Archives of Surgery. 2003;138(1):9–14. doi: 10.1001/archsurg.138.1.9.
Simmons LR, Molyneaux L, Yue DK, Chua EL. Steroid-induced diabetes: is it just unmasking of type 2 diabetes? ISRN Endocrinol. 2012;2012:910905.
Suarez-Alvarez Beatriz, Rodrigues Díez Raúl R. Mechanisms Underlying Diabetes-Associated Damage in Target Tissues, Frontiers in Pharmacology, 13, 2022. DOI=10.3389/fphar.2022.915806
Suh S, Park MK (2017) Glucocorticoid-induced diabetes mellitus: an important but overlooked problem. Endocrinol Metab (Seoul) 32: 180–9
Takeuchi, M., Sato, T., Sakurai, Y., et al. (2017) Association between Aqueous Humor and Vitreous Fluid Levels of Th17 Cell-Related Cytokines in Patients with Proliferative Diabetic Retinopathy. PLoS ONE, 12, e0178230.
https://doi.org/10.1371/journal.pone.0178230
Tamez-Perez HE, Quintanilla-Flores DE, Rodriguez-Gutierrez RR et al (2015) Steroid hyperglycaemia: Prevalence, early detection and therapeutic recommendations: A narrative review. World J Diabetes 6: 1073–81
Vaya A, Rivera L, de la Espriella R, Sanchez F, Suescun M, et al. Red blood cell distribution width and erythrocyte deformability in patients with acute myocardial infarction. Clin Hemorheol Microcirc. 2015; 59: 107-114. Ref.: https://goo.gl/kX9KB4
Vozarova B, Stefan N, Lindsay RS, Saremi A, Pratley RE, Bogardus C, Tataranni PA. High alanine aminotransferase is associated with decreased hepatic insulin sensitivity and predicts the development of type 2 diabetes. Diabetes. 2002 Jun;51(6):1889-95. doi: 10.2337/diabetes.51.6.1889. PMID: 12031978.
W.B. Kannel, K. Anderson, P.W. Wilson. White blood cell count and cardiovascular disease: insights from the Framingham Study JAMA, 267 (2) (1992), pp. 1253-1256
Wegner M., Winiarska H., Bobkiewicz-Kozlowska T., Dworacka M. IL-12 serum levels in patients with type 2 diabetes treated with sulphonylureas. Cytokine. 2008;42:312–316.
Yousefidaredor, H., et al. (2014) IL-17A Plays an Important Role in Induction of Type 2 Diabetes and Its Complications. Asian Pacific Journal of Tropical Disease, 4, 412-415.
https://doi.org/10.1016/S2222-1808(14)60598-3
Zeliha Hekimsoy, Bahriye Payzin, Talat Ornek, Gülgün Kandogan. Mean platelet volume in Type 2 diabetic patients. Journal of Diabetes and its Complications, 18 (3) (2004), pp. 173-176
View Dimensions
View Altmetric
Save
Citation
View
Share